<?xml version="1.0" encoding="UTF-8"?>
<ref id="B33-molecules-24-01552">
 <label>33.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tanamly</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Tadros</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Labeeb</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Makld</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Mikhail</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Abdel-Hamid</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Shehata</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Abu-Baki</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Medhat</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Magder</surname>
    <given-names>L.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: Study description and 12-month results</article-title>
  <source>Dig. Liver Dis.</source>
  <year>2004</year>
  <volume>36</volume>
  <fpage>752</fpage>
  <lpage>759</lpage>
  <pub-id pub-id-type="doi">10.1016/j.dld.2004.06.015</pub-id>
  <pub-id pub-id-type="pmid">15571006</pub-id>
 </element-citation>
</ref>
